Clinical outcomes of a 12-week, first treatment with methylphenidate in an Italian representative sample of children and adolescents with ADHD
Abstract Current clinical guidelines suggest methylphenidate (MPH) as first-line option for treatment of attention-deficit/hyperactivity disorder (ADHD). However, the Lombardy ADHD Registry initiative has recently raised some concerns about discrepant therapeutic approaches between different clinica...
Saved in:
| Main Authors: | Alessandro Crippa, Eleonora Rosi, Valentina Mauri, Angela Valli, Maria Nobile, Antonio Salandi, Sara Trabattoni, Massimo Molteni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-10684-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In silico investigation of ketamine and methylphenidate drug-drug conjugate for MDD and ADHD treatment using MD simulations and MMGBSA
by: Beenish Asrar, et al.
Published: (2025-07-01) -
Prescribing of methylphenidate to children and adolescents in South Africa: A pharmacoepidemiological investigation
by: Ilse Truter
Published: (2009-10-01) -
Attention-deficit/hyperactivity disorder
by: A. M.E. du Plessis
Published: (2015-05-01) -
Methylphenidate in Borderline Personality Disorder: Assessing Its Therapeutic Potential and Limitations
by: Simone Pardossi, et al.
Published: (2025-02-01) -
Comparative analysis of stress levels and coping strategies in parents of neurodivergent and neurotypical children
by: Lessa A. Méndez-Lara, et al.
Published: (2025-08-01)